Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism.
Coppedè F, Migheli F, Lopomo A, Failli A, Legitimo A, Consolini R, Fontanini G, Sensi E, Servadio A, Seccia M, Zocco G, Chiarugi M, Spisni R, Migliore L. Coppedè F, et al. Among authors: fontanini g. Epigenetics. 2014 Apr;9(4):621-33. doi: 10.4161/epi.27956. Epub 2014 Jan 31. Epigenetics. 2014. PMID: 24500500 Free PMC article.
Evaluation of telomerase mRNA (hTERT) in colon cancer.
Boldrini L, Faviana P, Gisfredi S, Zucconi Y, Di Quirico D, Donati V, Berti P, Spisni R, Galleri D, Materazzi G, Basolo F, Miccoli P, Pingitore R, Fontanini G. Boldrini L, et al. Among authors: fontanini g. Int J Oncol. 2002 Sep;21(3):493-7. doi: 10.3892/ijo.21.3.493. Int J Oncol. 2002. PMID: 12168091
Evaluation of telomerase in the development and progression of colon cancer.
Boldrini L, Faviana P, Gisfredi S, Zucconi Y, Di Quirico D, Donati V, Berti P, Spisni R, Galleri D, Materazzi G, Basolo F, Miccoli P, Pingitore R, Fontanini G. Boldrini L, et al. Among authors: fontanini g. Int J Mol Med. 2002 Nov;10(5):589-92. Int J Mol Med. 2002. PMID: 12373297
Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial.
Masi G, Loupakis F, Salvatore L, Fornaro L, Cremolini C, Cupini S, Ciarlo A, Del Monte F, Cortesi E, Amoroso D, Granetto C, Fontanini G, Sensi E, Lupi C, Andreuccetti M, Falcone A. Masi G, et al. Among authors: fontanini g. Lancet Oncol. 2010 Sep;11(9):845-52. doi: 10.1016/S1470-2045(10)70175-3. Epub 2010 Aug 9. Lancet Oncol. 2010. PMID: 20702138 Clinical Trial.
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan.
Loupakis F, Cremolini C, Fioravanti A, Orlandi P, Salvatore L, Masi G, Schirripa M, Di Desidero T, Antoniotti C, Canu B, Faviana P, Sensi E, Lupi C, Fontanini G, Basolo F, Di Paolo A, Danesi R, Falcone A, Bocci G. Loupakis F, et al. Among authors: fontanini g. Target Oncol. 2014 Sep;9(3):205-14. doi: 10.1007/s11523-013-0284-7. Epub 2013 Jul 3. Target Oncol. 2014. PMID: 23821377
Histo-cytological diagnostic accuracy in lung cancer.
Proietti A, Boldrini L, Alì G, Servadio A, Lupi C, Sensi E, Miccoli M, Ribechini A, Chella A, Lucchi M, Leocata P, Mussi A, Fontanini G. Proietti A, et al. Among authors: fontanini g. Cytopathology. 2014 Dec;25(6):404-11. doi: 10.1111/cyt.12117. Epub 2013 Nov 20. Cytopathology. 2014. PMID: 24251636
320 results